Coca-Cola HBC AG CCHBF OTC · Consumer defensive · Switzerland
$55.44 +0.00% +$0.00
Summary
72 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 31% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- Out of every 100 EUR of revenue, 8.1 EUR is left as net profit.
What to watch
- It missed profit estimates 8 times in the last 8 quarters.
- For every 100 EUR of shareholders' equity it carries 151 EUR of debt.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.3 EUR for 1 EUR of yearly profit. Over the last five years it was 17.5 EUR on average.
Valuation in detailIs it growing?
Yes, fastRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 7.4% a year. For the next fiscal year analysts expect revenue to grow by 7.9%. Earnings per share grew by 31% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 EUR of revenue goes
- Cost of sales 63 EUR
- Sales and administration 26 EUR
- Taxes and other 3.3 EUR
- Net profit 8.1 EUR
Net profit, industry median (Beverages - Non-Alcoholic) 8.6 EUR
Out of every 100 EUR of revenue, 8.1 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 8.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 2.53%
- Paid out of profit
- 46%
- Raised in a row
- 3 years
You receive $1.40 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.